Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1983 2
1984 3
1985 2
1986 6
1987 5
1988 4
1989 4
1990 9
1991 8
1992 9
1993 7
1994 9
1995 12
1996 11
1997 10
1998 17
1999 15
2000 17
2001 22
2002 11
2003 7
2004 7
2005 6
2006 17
2007 19
2008 18
2009 23
2010 15
2011 19
2012 25
2013 19
2014 15
2015 24
2016 20
2017 20
2018 12
2019 21
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

433 results
Results by year
Filters applied: . Clear all
Page 1
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.
Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Müller DJ, Parikh SV, Pearson NL, Ravindran AV, Uher R; CANMAT Depression Work Group. Kennedy SH, et al. Among authors: blier p. Can J Psychiatry. 2016 Sep;61(9):540-60. doi: 10.1177/0706743716659417. Epub 2016 Aug 2. Can J Psychiatry. 2016. PMID: 27486148 Free PMC article. Review.
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.
Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University, Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O'Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR. Katzman MA, et al. Among authors: blier p. BMC Psychiatry. 2014;14 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. BMC Psychiatry. 2014. PMID: 25081580 Free PMC article. Review.
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Daly EJ, Trivedi MH, Janik A, Li H, Zhang Y, Li X, Lane R, Lim P, Duca AR, Hough D, Thase ME, Zajecka J, Winokur A, Divacka I, Fagiolini A, Cubala WJ, Bitter I, Blier P, Shelton RC, Molero P, Manji H, Drevets WC, Singh JB. Daly EJ, et al. Among authors: blier p. JAMA Psychiatry. 2019 Jun 5;76(9):893-903. doi: 10.1001/jamapsychiatry.2019.1189. Online ahead of print. JAMA Psychiatry. 2019. PMID: 31166571 Free PMC article.
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele HVD, Preskorn S, Manji H, Hough D, Drevets WC, Singh JB. Fedgchin M, et al. Among authors: blier p. Int J Neuropsychopharmacol. 2019 Oct 1;22(10):616-630. doi: 10.1093/ijnp/pyz039. Int J Neuropsychopharmacol. 2019. PMID: 31290965 Free PMC article. Clinical Trial.
Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M, Blier P. Hamon M, et al. Among authors: blier p. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:54-63. doi: 10.1016/j.pnpbp.2013.04.009. Epub 2013 Apr 19. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23602950 Review.
Neurobiology of depression and mechanism of action of depression treatments.
Blier P. Blier P. J Clin Psychiatry. 2016 Mar;77(3):e319. doi: 10.4088/JCP.13097tx3c. J Clin Psychiatry. 2016. PMID: 27046319 Free article.
Ketamine for chronic depression: two cautionary tales.
Talbot J, Phillips JL, Blier P. Talbot J, et al. Among authors: blier p. J Psychiatry Neurosci. 2019 Nov 1;44(6):384-385. doi: 10.1503/jpn.190073. J Psychiatry Neurosci. 2019. PMID: 31573153 Free PMC article.
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Phillips JL, Norris S, Talbot J, Birmingham M, Hatchard T, Ortiz A, Owoeye O, Batten LA, Blier P. Phillips JL, et al. Among authors: blier p. Am J Psychiatry. 2019 May 1;176(5):401-409. doi: 10.1176/appi.ajp.2018.18070834. Epub 2019 Mar 29. Am J Psychiatry. 2019. PMID: 30922101 Clinical Trial.
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.
Lopez JP, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C, Han MH, Foster J, Frey BN, Soares CN, Müller DJ, Farzan F, Leri F, MacQueen GM, Feilotter H, Tyryshkin K, Evans KR, Giacobbe P, Blier P, Lam RW, Milev R, Parikh SV, Rotzinger S, Strother SC, Lewis CM, Aitchison KJ, Wittenberg GM, Mechawar N, Nestler EJ, Uher R, Kennedy SH, Turecki G. Lopez JP, et al. Among authors: blier p. Nat Commun. 2017 May 22;8:15497. doi: 10.1038/ncomms15497. Nat Commun. 2017. PMID: 28530238 Free PMC article. Clinical Trial.
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines.
Fountoulakis KN, Grunze H, Vieta E, Young A, Yatham L, Blier P, Kasper S, Moeller HJ. Fountoulakis KN, et al. Among authors: blier p. Int J Neuropsychopharmacol. 2017 Feb 1;20(2):180-195. doi: 10.1093/ijnp/pyw109. Int J Neuropsychopharmacol. 2017. PMID: 27941079 Free PMC article. Review.
433 results
Jump to page
Feedback